insitro Advances AI-Discovered CTRO-1013 for MASH With Anti-Fibrotic Data
NEW ORLEANS, June 8, 2026 insitro announced new preclinical findings from its lead metabolic dysfunction-associated steatohepatitis (MASH) program, demonstrating...
siRNA therapy
Advertisement
Brii Bio Reports Positive ENSURE HBV Cure Study Results
DURHAM, N.C. and BEIJING, China, May 27, 2026 Brii Biosciences Limited (Brii Bio) has presented new late-breaking clinical and...
Phio Pharmaceuticals Showcases PH-762 Skin Cancer Trial Progress
KING OF PRUSSIA, Pa., May 12, 2026 Phio Pharmaceuticals announced that company leadership will participate in a virtual fireside...
GSK Signs $1B SiranBio siRNA Cardiometabolic Deal
SUZHOU, China, May 6, 2026 SiranBio announced a major global licensing agreement with GSK for its investigational siRNA therapeutic...
Arrowhead Gains CHMP Nod for REDEMPLO in Rare Disease
Pasadena, California | April 24, 2026 Arrowhead Pharmaceuticals has achieved a major regulatory milestone as the Committee for Medicinal...
Advertisements
Atrium Therapeutics Earns $15M Milestone from Bristol Myers Squibb
San Diego, California, USA – April 23, 2026 Atrium Therapeutics announced it has achieved a $15 million development milestone...
Regeneron Cemdisiran Shows Strong gMG Phase 3 Results
Tarrytown, New York, USA – April 21, 2026 In a significant breakthrough for autoimmune neurology, Regeneron Pharmaceuticals has reported...
Advertisement
